- References
- External links
The Health Service Medical Supplies (Costs) Act 2017 (c 23) is an Act of the Parliament of the United Kingdom. It provides that pharmaceutical companies can be compelled to reduce the price of a generic medicine or introduce other controls on branded products in cases where charges are “unreasonable”.[1] References1. ^{{cite news|title=New legislation passed to prevent excessive price hiking of generic drugs|url=http://www.pharmaceutical-journal.com/20202701.article|accessdate=30 May 2017|publisher=Pharmaceutical Journal|date=3 May 2017}}
External links{{UK legislation}} 2 : United Kingdom Acts of Parliament 2017|NHS legislation |